21st July 2021

The clock is ticking! Have you appointed your National Contact Person for Pharmacovigilance yet?

By 1 January 2022 any European Marketing Authorisation Holders (MAH) who choose to establish a QPPV (Qualified Person for Pharmacovigilance) who resides and operates in the […]
19th March 2020

GCP Inspections: Expectations and the dos and don’ts for hosting

Good Clinical Practice (GCP) inspections and how they are conducted has evolved massively over the years and has had to, due to the increased complexity of […]
13th March 2020

Advice for Management of Clinical trials in relation to Coronavirus

As we are all now terribly aware, COVID-19 is proving to be a challenge across all areas of industry. Recently, the MHRA have announced on their […]
17th February 2020

Good news for severe migraine suffers everywhere as NICE agrees to look again at Novartis’ Aimovig for migraine prevention

The UK’s medicines cost-effectiveness agency NICE has agreed to look again at its decision to turn down NHS funding of Novartis’ Aimovig for migraine prevention after […]